Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/the-new-england-journal-of-medicine/bisphosphonate-induced-osteopetrosis-47vEIaQ1B0
References (23)
-
R. Follis, E. Park (1952)
Some observations on bone growth, with particular respect to zones and transverse lines of increased density in the metaphysis.The American journal of roentgenology, radium therapy, and nuclear medicine, 68 5
-
T. Srivastava, U. Alon (1999)
Bisphosphonates: From Grandparents to GrandchildrenClinical Pediatrics, 38
-
L. Shoemaker (1999)
Expanding role of bisphosphonate therapy in children.The Journal of pediatrics, 134 3
-
N. Camacho, C. Raggio, S. Doty, Leon Root, V. Zraick, W. Ilg, Talya Toledano, Adele Boskey (2001)
A Controlled Study of the Effects of Alendronate in a Growing Mouse Model of Osteogenesis ImperfectaCalcified Tissue International, 69
-
F. Glorieux, N. Bishop, H. Plotkin, G. Chabot, Ginette Lanoue, R. Travers (1998)
Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.The New England journal of medicine, 339 14
-
M. Whyte, S. Obrecht, P. Finnegan, Jonathan Jones, M. Podgornik, W. Mcalister, S. Mumm (2002)
Osteoprotegerin deficiency and juvenile Paget's disease.The New England journal of medicine, 347 3
-
J. Bollerslev, P. Andersen (1988)
Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis.Bone, 9 1
-
G. Isaia, R. Lala, C. Defilippi, P. Matarazzo, M. Andreo, C. Roggia, G. Priolo, C. Desanctis (2002)
Bone Turnover in Children and Adolescents with McCune-Albright Syndrome Treated with Pamidronate for Bone Fibrous DysplasiaCalcified Tissue International, 71
-
M. Whyte (1998)
Chapter 24 – Skeletal Disorders Characterized By Osteosclerosis Or Hyperostosis -
L. Bachrach, T. Hastie, May‐Choo Wang, B. Narasimhan, R. Marcus (1999)
Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study.The Journal of clinical endocrinology and metabolism, 84 12
-
C. Brumsen, Neveen Hamdy, S. Papapoulos (1997)
Long‐Term Effects of Bisphosphonates on the Growing Skeleton: Studies of Young Patients with Severe OsteoporosisMedicine, 76
-
K. Doorn, Bart Neyns, P. Niepen, D. Verbeelen (2001)
Pamidronate-Related Nephrotoxicity (Tubulointerstitial Nephritis) in a Patient with Osteolytic Bone MetastasesNephron, 89
-
Robert Martin, R. Deane, V. Collett (1997)
Spondylolysis in Children Who Have Osteopetrosis*The Journal of Bone & Joint Surgery, 79
-
M. Whyte, A. Chines, D. Silva, Y. Landt, J. Ladenson (1996)
Creatine kinase brain isoenzyme (BB‐CK) presence in serum distinguishes osteopetroses among the sclerosing bone disordersJournal of Bone and Mineral Research, 11
-
E. Meerten, H. Kroon, S. Papapoulos (1992)
Epi- and metaphyseal changes in children caused by administration of bisphosphonates.Radiology, 184 1
-
G Rodan, H Fleisch (1996)
Bisphosphonates: mechanisms of action.The Journal of clinical investigation, 97 12
-
Thompson Bh, Merritt Ad (1974)
Dominantly inherited periodic bone pain.Birth defects original article series, 10
-
K. Kruse (1985)
Normal bone turnover in isolated hyperphosphatasemia.The Journal of pediatrics, 106 6
-
S. Mumm, Jonathan Jones, P. Finnegan, P. Henthorn, M. Podgornik, M. Whyte (2002)
Denaturing gradient gel electrophoresis analysis of the tissue nonspecific alkaline phosphatase isoenzyme gene in hypophosphatasia.Molecular genetics and metabolism, 75 2
-
Erna Cleiren, O. Benichou, E. Hul, J. Gram, J. Bollerslev, Frederick Singer, K. Beaverson, A. Aledo, M. Whyte, T. Yoneyama, M. deVernejoul, W. Hul (2001)
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.Human molecular genetics, 10 25
-
A. Kinoshita, T. Saito, Hiro-aki Tomita, Y. Makita, Kunihiro Yoshida, M. Ghadami, Koki Yamada, S. Kondo, S. Ikegawa, G. Nishimura, Y. Fukushima, T. Nakagomi, H. Saito, Takeo Sugimoto, M. Kamegaya, Kenji Hisa, J. Murray, N. Taniguchi, N. Niikawa, K. Yoshiura (2000)
Domain-specific mutations in TGFB1 result in Camurati-Engelmann diseaseNature Genetics, 26
-
R. Lindsay (2002)
Modeling the benefits of pamidronate in children with osteogenesis imperfecta.The Journal of clinical investigation, 110 9
-
F. Rauch, R. Travers, H. Plotkin, F. Glorieux (2002)
The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.The Journal of clinical investigation, 110 9
- Publisher
- The New England Journal of Medicine
- Copyright
- Copyright © 2003 Massachusetts Medical Society. All rights reserved.
- ISSN
- 0028-4793
- eISSN
- 1533-4406
- DOI
- 10.1056/NEJMoa023110
- pmid
- 12890844
- Publisher site
- See Article on Publisher Site
Abstract
Bisphosphonates are increasingly used in conditions such as osteogenesis imperfecta and juvenile osteoporosis. Their potential adverse effects in growing children have been a concern, however, since bisphosphonates inhibit skeletal resorption by suppressing the activity and function of osteoclasts. The authors describe a case of drug-induced osteopetrosis in a 12-year-old boy who had received high doses of pamidronate for nearly three years.
Journal
The New England Journal of Medicine – The New England Journal of Medicine
Published: Jul 31, 2003